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Manometric and pharmacological tests have shown that motor abnor-
malities may occur in the non-dilated colons of chagasic patients. In
order to investigate the presence of abnormalities of colonic function
in constipated patients with Chagas disease (ChC) without megae-
sophagus or megacolon, studies of total and segmental colonic transit
time with radiopaque markers were performed on 15 ChC patients, 27
healthy volunteers and 17 patients with idiopathic constipation (IC).
The values obtained for the control group were similar to those
reported in the literature (total colonic time: 34.1 ± 15.6 h; right colon:
9.9 ± 7.3 h; left colon: 10.8 ± 10 h, and rectosigmoid: 12.6 ± 9.9 h).
Colonic transit time data permitted us to divide both IC and ChC
patients into groups with normal transit and those with slow colonic
transit. Colonic inertia was detected in 41% of IC patients and in 13%
of ChC patients; left colon isolated stasis (hindgut dysfunction) was
detected in 12% of IC patients and 7% of ChC patients, and outlet
obstruction was detected in 6% of IC patients and 7% of ChC patients.
There were no significant differences in total or segmental colonic
transit times between slow transit IC and slow transit ChC patients. In
conclusion, an impairment of colonic motility was detected in about
30% of constipated patients with Chagas disease without megae-
sophagus or megacolon. This subgroup of patients presented no
distinctive clinical feature or pattern of colonic dysmotility when
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Chronic intestinal constipation is one of
the most frequent complaints in clinical prac-
tice (1). In countries like Brazil, where
Chagas disease is endemic, constipation may
reflect disorders of colorectal motility in-
duced by the intrinsic denervation seen in
organs affected by this disease (2,3). Usu-
ally, the diagnosis of chagasic colopathy is
made only at the megacolon stage. However,
studies on small groups of patients using
pharmacological tests (4,5) or manometry
(6,7) have shown the presence of neural and
motor abnormalities in nondilated colons.
This suggests that, as already shown for the
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esophagus (8), the study of colonic motility
may identify functional abnormalities in a
stage preceding colon dilation.
The assessment of total and segmental
colonic transit time (CTT) with ingested ra-
diopaque markers (9,10) has been widely
employed to evaluate colorectal function in
constipated patients. It is a simple noninva-
sive technique, readily applicable within the
clinical context, which allows patients to be
classified into four groups: intestinal consti-
pation with normal colonic transit time, co-
lonic inertia (prolonged transit time through-
out the colons, especially the right colon),
hindgut dysfunction (prolonged transit time
in the left colon, but normal in the right one),
and outlet obstruction (prolonged transit time
in the rectosigmoid but normal in the re-
maining areas).
In the present study, this technique was
used to evaluate constipated patients with
Chagas disease (ChC) without megaesopha-
gus or megacolon in order to investigate: 1)
whether abnormalities of colonic function
could be demonstrated at this stage of the
disease and 2) to compare these abnormali-
ties with those found in a group of patients
with idiopathic intestinal constipation (IC).
Material and Methods
Study population
Table 1 shows the clinical features of the
study population. Informed written consent
was obtained from all subjects involved in
the study. The protocol was approved by
the Ethics Committee of the Hospital das
Clínicas, UNICAMP.
Control group. Twenty-seven healthy vol-
unteers (14 males and 13 females) were
recruited from the medical and paramedical
staff. The selection criteria included a stool
frequency of 2 stools/day to 3 stools/week,
no difficulty in passing stools and normal
stool consistency. No subject was taking any
medication known to affect gastrointestinal
motility or reported changes in bowel move-
ments induced by stress. No volunteer had
an epidemiological background for Chagas
disease.
Patients with IC. This group consisted of
17 patients (16 females and 1 male) who
were referred to our outpatient clinic for
evaluation of chronic constipation, defined
as less than 3 stools/week and passing of
hard stools for at least one year. All patients
had barium enema to document the absence
of any organic colonic lesions and serologic
tests to exclude Chagas disease. There was
no clinical evidence of diabetes mellitus,
collagen disease or neurological disorders.
Patients with ChC. These patients were
selected from a group regularly followed up
at GEDOCH (Chagas disease study group)
with positive serologic reactions (comple-
ment fixation test and/or immunofluores-
cence reaction) for Chagas disease, with no
evidence of heart failure, megaesophagus or
megacolon, with the latter two being con-
firmed by esophagogram and barium enema.
Fifteen consecutive patients (10 females and
5 males) who also fulfilled the criteria for a
diagnosis of chronic constipation in a sepa-
rate interview assessing specifically their
bowel habits were enrolled in the study.
There was no clinical evidence of diabetes
mellitus or collagen disease in this group.
The symptoms of constipation were similar
to those reported by IC, but fewer patients
reported the use of laxatives to promote
evacuation (Table 1).
Colonic transit studies
Total and segmental CTT was assessed
as previously described by Metcalf et al.
(10). Patients were asked to maintain their
usual diet and received a fiber supplement of
20 g/day (Metamucil®, Procter & Gamble,
São Paulo, SP, Brazil) for one week before
and during the study. Laxatives and medica-
tions known to affect colonic motility were
not permitted during the study. All partici-
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pants ingested 24 radiopaque markers con-
tained within a gelatin capsule (SITZMARKS®,
Konsyl Pharmaceuticals Inc., Fort Worth,
TX, USA) at the same time, after breakfast,
on three consecutive days. An abdominal X-
ray was taken on days 4 and 7 at the time of
marker ingestion. Markers were identified
and counted on the abdominal films. The
right colon, left colon and rectosigmoid were
recognized by bony landmarks and/or by
their clear identification due to gas shadows
as described by Arhan et al. (9). The spinal
processes and imaginary lines from the fifth
lumbar vertebra to the pelvic outlet served as
landmarks.
Total and segmental CTT were then cal-
culated using the following formula:
where Dt = mean transit time, T = time
interval between X-rays, N = number of
ingested markers, j = number of X-rays taken,
and ni = total number of markers present on
a given film sector at time ti. Since the ab-
dominal X-rays were always taken at 72-h
intervals and the total number of markers
was kept constant at 72, the above formula
can be simplified to:
Statistical analysis
Results are reported as mean ± SD. The
upper limits of normality of colonic transit
times were considered as the mean + 2 SD.
The results were analyzed by the Mann-
Whitney test for comparison of quantitative
data and by the chi-square test or Fishers
exact test for comparison of qualitative data.
Differences were considered statistically sig-
nificant when P<0.05.
Results
Table 2 shows the mean values of total
and segmental CTT for controls and pa-
tients.
Control group
The upper limits of normality for total
and segmental CTT were: total colonic tran-
sit time = 65 h; right colonic transit time = 25
h; left colonic transit time = 31 h, and rec-
tosigmoid transit time = 32 h. No statistically
Table 1 - Clinical features of the study population.
IC, Idiopathic constipation; ChC, Chagas’ disease constipation. *P<0.05 vs controls
and **P<0.05 vs ChC (c2 and Fisher’s exact tests).
Variables IC (N = 17) ChC (N = 15) Control (N = 27)
Mean age ± SD (years) 35 ± 11 48 ± 11* 41 ± 12
Gender (% females) 94.2* 66.6* 48.1
Symptoms duration (years) >7 >10 -
Bowel movements/week 1 1-2 3-14
Straining (%) 71 80 -
Hard stools (%) 94 93 -
Laxative use (%) 100** 66.6 -
Table 2 - Total and segmental colonic transit time (CTT) in patients with idiopathic
constipation (IC) and constipated patients with Chagas’ disease (ChC).
Data are reported as means ± SD in hours. In patients with slow transit constipation
the values of total CTT are above the upper limits of normality. TCTT: Total CTT; RCTT:
right CTT; LCTT: left CTT, and RSTT: rectosigmoid transit time.
TCTT RCTT LCTT RSTT
Controls 34.1 ± 15.6 9.9 ± 7.4 10.8 ± 10 12.6 ± 10
Upper normal limits 65 25 31 32
Normal transit IC 39.2 ± 17 18.1 ± 15 12.2 ± 13.1 9 ± 6
Normal transit ChC 42.5 ± 15.1 11.0 ± 10 12.8 ± 10 17.9 ± 13
Slow transit IC 110.4 ± 30.4 36.4 ± 27.3 46.0 ± 29 28 ± 24.6
Slow transit ChC 100.2 ± 25.6 25.7 ± 17.3 45.2 ± 41.7 29.2 ± 31.2
Table 3 - Effect of age and gender on total and segmental colonic transit times (CTT) in
27 healthy volunteers.
Results are reported as mean ± SD hours. For abbreviations see legend to Table 2.
TCTT RCTT LCTT RSTT
Male (N = 14) 30.7 ± 17.1 9.4 ± 6.9 8.7 ± 11.4 12.1 ± 9.9
Female (N = 13) 37.7 ± 13.5 7.0 ± 8.1 13.5 ± 8.1 14.5 ± 10.2
Age >40 years (N = 8) 32.3 ± 11 13.2 ± 6.5 10.4 ± 9.7 11.5 ± 12.2
<40 years (N = 19) 34.8 ± 17.2 10.2 ± 7.9 11.0 ± 10.4 13.7 ± 10.5
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when a decrease of markers was observed on
the X-ray. IC and ChC patients were divided
according to total CTT into those with nor-
mal transit and those with slow transit,
the latter when total CTT was longer than 65
h (Figure 1). Slow colonic transit was shown
in 65% of IC (11 out of 17, 10 females) and
27% of ChC (4 out of 15, 3 females; P =
0.03). There was no difference between slow
transit IC and slow transit ChC patients in
total CTT (Table 2). In addition, all patients
with prolonged transit reported the chronic
use of laxatives.
Segmental CTT. The study of the seg-
mental CTT classified slow colonic transit
patients into the subgroups previously de-
fined (Figures 2-4). Among IC patients, 41%
(7 of 17) had a pattern of colonic inertia,
12% (2) had hindgut dysfunction, 6% (1)
had outlet obstruction, and 6% (1) showed a
prolonged total CTT with normal segmental
transit time. Among ChC patients, 13% (2)
showed a pattern of colonic inertia, 7% (1)
had hindgut dysfunction and 7% (1) had
outlet obstruction.
Discussion
The study of total and segmental colonic
transit times with radiopaque markers proved
to be a simple, practical and reliable method.
The results obtained for our control group
are comparable to those described in the
literature, including a Brazilian study (11).
No significant difference in colonic transit
times was found between our male and fe-
male controls. Gender effect on colonic tran-
sit time has been controversial. Many stud-
ies have reported a more prolonged colonic
transit in women (10,11). However, these
differences have been recently attributed to
subject selection (12,13). It has been sug-
gested that many women recruited as healthy
controls may suffer from irritable bowel syn-
drome. It is possible that our routine of ask-
ing subjects about changes in bowel habits
induced by stress contributed to our findings
Figure 1 - Total colonic tran-
sit time (TCTT) in patients
with idiopathic constipation
(IC) and constipated pa-
tients with Chagas’ disease
(ChC) without megacolon.
The horizontal dotted line
indicates the upper limits of
normality of the test. Both
IC and ChC have been di-
vided into those with nor-
mal transit and those with
slow transit on the basis of
the dotted line.
Figure 2 - Colonic inertia in a constipated patient with Chagas’ disease (ChC). An X-ray












significant effect of age or gender on colonic
transit times was demonstrable (Table 3),
although there was a trend for women to
present a slower left colon transit than men.
Patient groups
Total CTT. No patient denied evacuation
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Figure 4 - Outlet obstruction in a patient with idiopathic constipation (IC).
An X-ray taken on day 4 shows aggregation of markers in the rectosigmoid.
The same pattern was observed on day 7.
of similar results for men and women. Age
also did not influence colonic transit time,
confirming previous reports (10).
Colonic transit of radiopaque markers
divided both IC and ChC patients into those
with normal CTT and those with prolonged
CTT. The complaints of constipation in pa-
tients with normal transit time have been
associated either with a low fiber diet or with
psychological disorders (14). Since the in-
gestion of fibers varied among our patients,
and considering that a fiber supplement may
be helpful to exclude a low fiber intake as a
cause of constipation (12), the diets of our
patients were enriched with 20 g of fiber.
Although it seems reasonable to assume that
most of our patients with normal transit were
constipated for dietary reasons, it is difficult
to determine it from our data, since previous
CTT studies without fiber supplement had
not been performed on these patients. Like-
wise, our study was not designed to assess
the role of psychological factors in these
patients.
Although the symptoms of constipation
were similar for all patients of both groups,
slow colonic transit was observed only in
27% of ChC patients and 65% of IC patients.
These findings agree with several studies
which have demonstrated the limited useful-
ness of clinical symptoms and physical ex-
amination in distinguishing constipated pa-
tients with normal or delayed colonic transit
(15). Therefore, measurements of colonic
transit time provide an objective assessment
for this heterogeneous condition.
The proportion of slow colonic transit
observed among our ChC patients was simi-
lar to that reported by Pemberton et al. (16)
who found a demonstrable abnormality in
Figure 3 - Hindgut dysfunction in a patient with idiopathic constipation
(IC). An abdominal X-ray taken on day 7 shows stasis of radiopaque
markers in the left colon.
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29% of 277 patients with constipation seen
at the Mayo Clinic. However, the frequency
of colonic transit dysfunction reported in the
literature varies widely (30-80%) (17). It has
been suggested that these abnormalities may
be more frequent among constipated patients
referred to tertiary gastroenterology prac-
tices. This might be one explanation for the
higher frequency of slow transit found a-
mong our IC patients, all of them referred to
our clinic for the evaluation of constipation.
One possible pathogenic mechanism for
prolonged colonic transit in ChC patients
may be the colonic denervation due to
Chagas disease. Alternatively, slow transit
in these patients may be associated with the
same pathogenic factors related to idiopathic
constipation. Abnormalities of the myen-
teric and submucosal plexuses have been
shown in colonic tissue of patients with idio-
pathic constipation submitted to colectomy
(18). One of the factors implicated in the
enteric neuropathy shown by those patients
is the long-term use of laxatives (19). It is
noteworthy that the chronic use of laxatives
was reported by all IC and ChC patients with
slow colonic transit.
Moreover, slow transit patients of both
groups also had in common the female pre-
ponderance and the low rate of delayed rec-
tosigmoid transit. Our data agree with those
of studies of idiopathic constipation which
have shown that slow colonic transit is al-
most exclusively confined to women (20,21).
On the other hand, in contrast to the higher
proportion of females found in our ChC
group, the proportion of males and females
is almost the same among patients with cha-
gasic megacolon (22).
Colonic inertia was the main pattern of
colonic dysfunction, observed in 43% and
13% of IC and ChC patients, respectively,
followed by hindgut dysfunction and outlet
obstruction. Based on the knowledge of the
colonic involvement in Chagas disease,
which shows a preferential dilation of rec-
tosigmoid (23), a delayed rectosigmoid tran-
sit might be expected as the main dysfunc-
tion in our ChC patients. However, despite
the small number of ChC patients with slow
transit, the abnormalities detected apparently
followed the same distribution as seen for IC
patients: colonic inertia, hindgut dysfunc-
tion and outlet obstruction, the latter present
in only one chagasic patient.
It is tempting to assume from the data
discussed above that the colonic dysfunction
found in this particular group of patients
with Chagas disease may be related to the
same underlying factors responsible for id-
iopathic constipation, such as the denerva-
tion induced by laxative abuse. Our selec-
tion of chagasic patients excluded those with
esophagopathy, a fact that may have ac-
counted for the low rate of rectosigmoid
transit abnormalities in this group. It is known
from Chagas disease natural history that
megacolon is recognized later than megae-
sophagus, due to either a slower evolution or
to a delay in seeking medical care (22).
However, previous pharmacological studies
investigating denervation (4) have reported
that 20% of cases of nondilated sigmoid
colon in patients with megaesophagus
showed hyper-reactivity to metacholine.
Therefore, additional studies of colonic tran-
sit time in patients with megaesophagus are
indicated.
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